Results 191 to 200 of about 101,166 (275)

Flow cytometric analysis and sorting of HLA-DR+CD1+ Langerhans cells [PDF]

, 1989
J. Ashworth, M Kahan, S.M. BREATHNACH
openalex   +1 more source

Frequency and Implications of High‐Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort

Clinical and Translational Science, Volume 18, Issue 5, May 2025.
ABSTRACT Pharmacogenomics remains underutilized in pediatric oncology, despite the existence of evidence‐based guidelines. Implementation of pharmacogenomics‐informed prescribing could improve medication safety and efficacy in pediatric oncology patients, who are at high risk of adverse drug reactions.
Claire Moore, Andreas Halman, Tayla Stenta, Dhrita Khatri, Elizabeth Williams, Roxanne Dyas, Julian Stolper, David A. Elliott, Rachel Conyers   +8 more
wiley   +1 more source

Langerhans Cells Directly Interact with Resident T Cells in the Human Epidermis. [PDF]

JID Innov
Oka T, Hasegawa T, Lee T, Oliver-Garcia VS, Mortaja M, Azin M, Horiba S, Smith SS, Khattab S, Trerice KE, Chen ST, Semenov YR, Demehri S.   +12 more
europepmc   +1 more source

TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms. [PDF]

Proc Natl Acad Sci U S A, 2023
Mariotton J, Cohen E, Zhu A, Auffray C, Barbosa Bomfim CC, Barry Delongchamps N, Zerbib M, Bomsel M, Ganor Y.   +8 more
europepmc   +1 more source

POTASSIUM AND RUBIDIUM PERMEABILITY AND POTASSIUM CONDUCTANCE OF THE β‐CELL MEMBRANE IN MOUSE ISLETS OF LANGERHANS [PDF]

, 1986
C M Dawson, P. C. Croghan, A. M. Scott, Jenny Bangham   +3 more
openalex   +1 more source

A Novel Polymersome Nanocarrier Promotes Anti‐Tumour Immunity by Improved Priming of CD8 + T Cells

Immunology, Volume 175, Issue 1, Page 21-35, May 2025.
Here, we show that subcutaneous injection of novel artificial cell membrane (ACM) polymersomes loaded with tumour‐specific antigens or peptides, such as OVA, results in efficient anti‐tumour immune responses. In both, a therapeutic and a prophylactic model, we found that ACMs were efficiently taken up by antigen presenting cells, such as dendritic ...
Regine J. Dress, William W. Ho, Victor Ho, Jian Hang Lam, Fabien M. Décaillot, Gaurav Sinsinbar, Jenetta Soo, Gowshika Rengasamy, Amit Kumar Khan, Thomas Andrew Cornell, Teck Wan Chia, Shrinivas Venkataraman, Madhavan Nallani, Florent Ginhoux   +13 more
wiley   +1 more source

Epithelial RANKL Limits Experimental Periodontitis via Langerhans Cells. [PDF]

J Dent Res
Netanely Y, Barel O, Naamneh R, Jaber Y, Yacoub S, Saba Y, Zubeidat K, Saar O, Eli-Berchoer L, Yona S, Brand A, Capucha T, Wilensky A, Loser K, Clausen BE, Hovav AH.   +15 more
europepmc   +1 more source

Abnormal lipid metabolism in epidermal Langerhans cells mediates psoriasis-like dermatitis. [PDF]

JCI Insight, 2022
Zhang X, Li X, Wang Y, Chen Y, Hu Y, Guo C, Yu Z, Xu P, Ding Y, Mi QS, Wu J, Gu J, Shi Y.   +12 more
europepmc   +1 more source

Darier disease: Current insights and challenges in pathogenesis and management

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 942-951, May 2025.
Darier disease (DD) is characterized by the following: Disrupted Ca2+ gradients, impaired desmosomes, impaired keratinocyte differentiation, type 17 inflammation, DC and LC ↓, Th17 cells ↑. DD treatment: First line: keratinocyte focused and/or anti‐inflammatory. Second line: experimental approaches like specific targeting of the inflammatory infiltrate.
Monika Ettinger, Susanne Kimeswenger, Isabella Deli, Judith Traxler, Sabine Altrichter, Petar Noack, Jakob D. Wikstrom, Emmanuella Guenova, Wolfram Hoetzenecker   +8 more
wiley   +1 more source

Langerhans cells: Central players in the pathophysiology of atopic dermatitis. [PDF]

J Eur Acad Dermatol Venereol
Pan Y, Hochgerner M, Cichoń MA, Benezeder T, Bieber T, Wolf P.   +5 more
europepmc   +1 more source